Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Anastrozole (Arimidex)|DRUG: Goserelin (Zoladex)
Sponsor: Stanford University
Collaborators: AstraZeneca